The department of Pharmaceutical Sciences and the College of Pharmacy's BioInnovations in Brain Cancer Initiative (BIBC), seeks highly qualified applicants for tenure-track position at any level in brain cancer biology and technology research (including, drug/molecular transport/imaging in the brain tissue, cellular and exosome mediated therapies, detection of cancer cells and biomarkers, translation-focused glioma, immune therapies, epigenetics and/or 3D single cell transcriptomics, blood-brain disruption, and drug/gene delivery.)
The University of Michigan BioInnovations in Brain Cancer seeks to:
- Promote and develop cross-disciplinary collaborations at the interface of drug technology and brain cancer research on campus.
- Mentor the next diverse generation of scientists in an equitable and inclusive way.
- Enrich the U-M's intellectual and training environment around drug discovery, technology and delivery targeted towards novel brain tumor diagnostics and therapeutics.
- Leverage and coalesce the strengths of the U-M technologists, clinicians, and brain cancer biology researchers, ranging from novel drug delivery methods, enhanced tissue imaging, gene/immunotherapy, controlled drug release, cancer antigen and mutation detection, nanotechnology, and much more.
- Provide a central organizational structure through the Biointerfaces Institute to provide common resources, including core instrumentation and helping support collaborative research grants.